What the Research Says
Schisandra is a well-researched adaptogen with diverse applications in health and wellness. A comprehensive review by Panossian and Wikman (2008) highlights its hepatoprotective, antioxidant, and adaptogenic properties. Recent studies further support these findings, particularly in the context of liver protection. Huang et al. (2025) conducted a systematic review and meta-analysis of 54 animal studies, demonstrating that Schisandra chinensis significantly reduces liver injury biomarkers such as ALT, AST, ALP, MDA, TNF-α, IL-6, and IL-1β, while increasing antioxidant enzymes like SOD and GSH. This underscores its potent hepatoprotective effects.
Beyond liver health, Schisandra has shown promise in other areas. For instance, Kim et al. (2022) conducted a randomized, double-blind, placebo-controlled trial with 80 participants and found that Omija extract mixture significantly reduced fasting and postprandial glucose levels in individuals with hyperglycemia. Additionally, Karosanidze et al. (2022) reported that adaptogens, including Schisandra, improved physical performance and reduced fatigue duration in Long COVID patients compared to placebo.
Schisandra's benefits extend to animal studies as well. Lee et al. (2025) found that a feed additive containing Schisandra chinensis by-products enhanced egg weight, egg mass, bone mineral density, and gut microbiota composition in laying hens. These findings suggest potential applications in agriculture and animal health.
Overall, Schisandra exhibits a broad range of therapeutic effects supported by robust scientific evidence.
